Lustra-af

— THERAPEUTIC CATEGORIES —
  • Pigmentation disorders

Lustra-af Generic Name & Formulations

General Description

Hydroquinone 4%; crm; contains sunscreens, sulfites.

Pharmacological Class

Depigmenting agent.

See Also

How Supplied

Crm—1oz, 2oz

Manufacturer

Lustra-af Indications

Indications

UV-induced skin dyschromia and discoloration due to hormonal changes or skin trauma.

Lustra-af Dosage and Administration

Adult

Apply to affected areas twice daily. Discontinue if lightening effect does not occur after 2 months.

Children

Not recommended.

Lustra-af Contraindications

Not Applicable

Lustra-af Boxed Warnings

Not Applicable

Lustra-af Warnings/Precautions

Warnings/Precautions

Do skin sensitivity test before use; do not use if itching, vesicle formation or excessive inflammation occurs. Avoid sun and UV light. Not for use as a sunscreen. Avoid eyes. Pregnancy (Cat.C). Nursing mothers.

Lustra-af Pharmacokinetics

See Literature

Lustra-af Interactions

Not Applicable

Lustra-af Adverse Reactions

Adverse Reactions

Contact dermatitis.

Lustra-af Clinical Trials

See Literature

Lustra-af Note

Not Applicable

Lustra-af Patient Counseling

See Literature